CTOs on the Move

Queens-Long Island Medical Group, P.C.

www.qlimg.com

 
Queens-Long Island Medical Group, P.C. is a Garden City, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.qlimg.com
  • 1000 Zeckendorf Blvd
    Garden City, NY USA 11530
  • Phone: 516.542.5500

Executives

Name Title Contact Details

Similar Companies

AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that spans the discovery, development, manufacturing, distribution and worldwide commercialisation of primary care and speciality care medicines. We believe the best way we can help patients is to focus on breakthrough science in order to uncover disease mechanisms and develop novel, targeted therapies that interact with them. This is at the heart of our purpose as a company: to push the boundaries of science to deliver life-changing medicines. We invest in distinctive science in three main therapy areas where we believe we can make the most meaningful difference to patients: oncology; cardiovascular and metabolic diseases; and respiratory, inflammation and autoimmunity. Our science exploits our rare combination of capabilities in small molecules and biologics, immunotherapies, protein engineering technologies and devices. These are reinforced by a strong focus on translational science and personalised healthcare capabilities. We build on our own capabilities by collaborating with world-renowned scientists and academic institutions and partnering with like-minded science-led companies. Through leading in science, we are confident that we can transform the lives of people around the world and deliver value to our shareholders.

Careguide Systems

Careguide Systems is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Verim Research

Verim Research is a Hood River, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lindora

Lindora is a Costa Mesa, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Parker Institute for Cancer Immunotherapy

For decades, entrenched infrastructure barriers have slowed progress in the fight against cancer and the development of potent immunotherapies. The Parker Institute for Cancer Immunotherapy breaks down these barriers. The result is groundbreaking new research and an intellectual property model that builds collaboration between researchers, nonprofits and industry all working together to get treatments to patients faster.